Recently, the National Library of Medicine (NLM) released two updates to ClinicalTrials.gov Protocol Registration and Results System (PRS) resources. The first is an update to the FAQs to explain the good cause extension request deadlines for clinical trials that are prematurely terminated more than one year after the date of completion.
The How to Register Your Study page now includes additional information on registering expanded access records under the Considerations for Observational Studies and Expanded Access Records section along with additional information from the FDA and NIH websites.
Review both to make sure you are up-to-date with the latest information from Clinictrials.gov.
 
                                        
                                                                        
                                                                                    NLM ClinicalTrials.gov
                                                                                                                                                                                                            
                                                                                                    How to Register Your Study                                                                                            
                                                                            
                                 
                                        
                                                                        
                                                                                    NLM ClinicalTrials.gov
                                                                                                                                                                                                            
                                                                                                    Frequently Asked Questions                                                                                            
                                                                            
                                 
				



 
										 
										